Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review)
Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails si...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
L. A. Miroshnichenko [verfasserIn] T. Yu. Polyakova [verfasserIn] E. Yu. Avdeeva [verfasserIn] S. V. Krivoshchekov [verfasserIn] I. A. Khlusov [verfasserIn] M. V. Belousov [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Разработка и регистрация лекарственных средств - LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020, 11(2022), 4, Seite 60-71 |
|---|---|
| Übergeordnetes Werk: |
volume:11 ; year:2022 ; number:4 ; pages:60-71 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.33380/2305-2066-2022-11-4-60-71 |
|---|
| Katalog-ID: |
DOAJ088666379 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ088666379 | ||
| 003 | DE-627 | ||
| 005 | 20230503024031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230410s2022 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.33380/2305-2066-2022-11-4-60-71 |2 doi | |
| 035 | |a (DE-627)DOAJ088666379 | ||
| 035 | |a (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a HD9665-9675 | |
| 100 | 0 | |a L. A. Miroshnichenko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. | ||
| 650 | 4 | |a хелидоновая кислота | |
| 650 | 4 | |a хелидонат кальция | |
| 650 | 4 | |a производные γ-пирона | |
| 650 | 4 | |a остеогенная активность | |
| 650 | 4 | |a остеопротекторы | |
| 653 | 0 | |a Pharmaceutical industry | |
| 700 | 0 | |a T. Yu. Polyakova |e verfasserin |4 aut | |
| 700 | 0 | |a E. Yu. Avdeeva |e verfasserin |4 aut | |
| 700 | 0 | |a S. V. Krivoshchekov |e verfasserin |4 aut | |
| 700 | 0 | |a I. A. Khlusov |e verfasserin |4 aut | |
| 700 | 0 | |a M. V. Belousov |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Разработка и регистрация лекарственных средств |d LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 |g 11(2022), 4, Seite 60-71 |w (DE-627)1760622966 |x 26585049 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:4 |g pages:60-71 |
| 856 | 4 | 0 | |u https://doi.org/10.33380/2305-2066-2022-11-4-60-71 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e |z kostenfrei |
| 856 | 4 | 0 | |u https://www.pharmjournal.ru/jour/article/view/1359 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2305-2066 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-5049 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 4 |h 60-71 | ||
| author_variant |
l a m lam t y p typ e y a eya s v k svk i a k iak m v b mvb |
|---|---|
| matchkey_str |
article:26585049:2022----::hldnccdniseiaegnrlpcrmfilgclciiyno |
| hierarchy_sort_str |
2022 |
| callnumber-subject-code |
HD |
| publishDate |
2022 |
| allfields |
10.33380/2305-2066-2022-11-4-60-71 doi (DE-627)DOAJ088666379 (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e DE-627 ger DE-627 rakwb rus HD9665-9675 L. A. Miroshnichenko verfasserin aut Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы Pharmaceutical industry T. Yu. Polyakova verfasserin aut E. Yu. Avdeeva verfasserin aut S. V. Krivoshchekov verfasserin aut I. A. Khlusov verfasserin aut M. V. Belousov verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 11(2022), 4, Seite 60-71 (DE-627)1760622966 26585049 nnns volume:11 year:2022 number:4 pages:60-71 https://doi.org/10.33380/2305-2066-2022-11-4-60-71 kostenfrei https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e kostenfrei https://www.pharmjournal.ru/jour/article/view/1359 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 11 2022 4 60-71 |
| spelling |
10.33380/2305-2066-2022-11-4-60-71 doi (DE-627)DOAJ088666379 (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e DE-627 ger DE-627 rakwb rus HD9665-9675 L. A. Miroshnichenko verfasserin aut Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы Pharmaceutical industry T. Yu. Polyakova verfasserin aut E. Yu. Avdeeva verfasserin aut S. V. Krivoshchekov verfasserin aut I. A. Khlusov verfasserin aut M. V. Belousov verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 11(2022), 4, Seite 60-71 (DE-627)1760622966 26585049 nnns volume:11 year:2022 number:4 pages:60-71 https://doi.org/10.33380/2305-2066-2022-11-4-60-71 kostenfrei https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e kostenfrei https://www.pharmjournal.ru/jour/article/view/1359 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 11 2022 4 60-71 |
| allfields_unstemmed |
10.33380/2305-2066-2022-11-4-60-71 doi (DE-627)DOAJ088666379 (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e DE-627 ger DE-627 rakwb rus HD9665-9675 L. A. Miroshnichenko verfasserin aut Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы Pharmaceutical industry T. Yu. Polyakova verfasserin aut E. Yu. Avdeeva verfasserin aut S. V. Krivoshchekov verfasserin aut I. A. Khlusov verfasserin aut M. V. Belousov verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 11(2022), 4, Seite 60-71 (DE-627)1760622966 26585049 nnns volume:11 year:2022 number:4 pages:60-71 https://doi.org/10.33380/2305-2066-2022-11-4-60-71 kostenfrei https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e kostenfrei https://www.pharmjournal.ru/jour/article/view/1359 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 11 2022 4 60-71 |
| allfieldsGer |
10.33380/2305-2066-2022-11-4-60-71 doi (DE-627)DOAJ088666379 (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e DE-627 ger DE-627 rakwb rus HD9665-9675 L. A. Miroshnichenko verfasserin aut Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы Pharmaceutical industry T. Yu. Polyakova verfasserin aut E. Yu. Avdeeva verfasserin aut S. V. Krivoshchekov verfasserin aut I. A. Khlusov verfasserin aut M. V. Belousov verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 11(2022), 4, Seite 60-71 (DE-627)1760622966 26585049 nnns volume:11 year:2022 number:4 pages:60-71 https://doi.org/10.33380/2305-2066-2022-11-4-60-71 kostenfrei https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e kostenfrei https://www.pharmjournal.ru/jour/article/view/1359 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 11 2022 4 60-71 |
| allfieldsSound |
10.33380/2305-2066-2022-11-4-60-71 doi (DE-627)DOAJ088666379 (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e DE-627 ger DE-627 rakwb rus HD9665-9675 L. A. Miroshnichenko verfasserin aut Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы Pharmaceutical industry T. Yu. Polyakova verfasserin aut E. Yu. Avdeeva verfasserin aut S. V. Krivoshchekov verfasserin aut I. A. Khlusov verfasserin aut M. V. Belousov verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 11(2022), 4, Seite 60-71 (DE-627)1760622966 26585049 nnns volume:11 year:2022 number:4 pages:60-71 https://doi.org/10.33380/2305-2066-2022-11-4-60-71 kostenfrei https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e kostenfrei https://www.pharmjournal.ru/jour/article/view/1359 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 11 2022 4 60-71 |
| language |
Russian |
| source |
In Разработка и регистрация лекарственных средств 11(2022), 4, Seite 60-71 volume:11 year:2022 number:4 pages:60-71 |
| sourceStr |
In Разработка и регистрация лекарственных средств 11(2022), 4, Seite 60-71 volume:11 year:2022 number:4 pages:60-71 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы Pharmaceutical industry |
| isfreeaccess_bool |
true |
| container_title |
Разработка и регистрация лекарственных средств |
| authorswithroles_txt_mv |
L. A. Miroshnichenko @@aut@@ T. Yu. Polyakova @@aut@@ E. Yu. Avdeeva @@aut@@ S. V. Krivoshchekov @@aut@@ I. A. Khlusov @@aut@@ M. V. Belousov @@aut@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
1760622966 |
| id |
DOAJ088666379 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ088666379</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503024031.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230410s2022 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.33380/2305-2066-2022-11-4-60-71</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ088666379</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665-9675</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">L. A. Miroshnichenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">хелидоновая кислота</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">хелидонат кальция</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">производные γ-пирона</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеогенная активность</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеопротекторы</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. Yu. Polyakova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. Yu. Avdeeva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Krivoshchekov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. A. Khlusov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. V. Belousov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Разработка и регистрация лекарственных средств</subfield><subfield code="d">LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020</subfield><subfield code="g">11(2022), 4, Seite 60-71</subfield><subfield code="w">(DE-627)1760622966</subfield><subfield code="x">26585049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:60-71</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.33380/2305-2066-2022-11-4-60-71</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.pharmjournal.ru/jour/article/view/1359</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2305-2066</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">4</subfield><subfield code="h">60-71</subfield></datafield></record></collection>
|
| callnumber-first |
H - Social Science |
| author |
L. A. Miroshnichenko |
| spellingShingle |
L. A. Miroshnichenko misc HD9665-9675 misc хелидоновая кислота misc хелидонат кальция misc производные γ-пирона misc остеогенная активность misc остеопротекторы misc Pharmaceutical industry Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) |
| authorStr |
L. A. Miroshnichenko |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760622966 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
HD9665-9675 |
| illustrated |
Not Illustrated |
| issn |
26585049 |
| topic_title |
HD9665-9675 Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) хелидоновая кислота хелидонат кальция производные γ-пирона остеогенная активность остеопротекторы |
| topic |
misc HD9665-9675 misc хелидоновая кислота misc хелидонат кальция misc производные γ-пирона misc остеогенная активность misc остеопротекторы misc Pharmaceutical industry |
| topic_unstemmed |
misc HD9665-9675 misc хелидоновая кислота misc хелидонат кальция misc производные γ-пирона misc остеогенная активность misc остеопротекторы misc Pharmaceutical industry |
| topic_browse |
misc HD9665-9675 misc хелидоновая кислота misc хелидонат кальция misc производные γ-пирона misc остеогенная активность misc остеопротекторы misc Pharmaceutical industry |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Разработка и регистрация лекарственных средств |
| hierarchy_parent_id |
1760622966 |
| hierarchy_top_title |
Разработка и регистрация лекарственных средств |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760622966 |
| title |
Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) |
| ctrlnum |
(DE-627)DOAJ088666379 (DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e |
| title_full |
Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) |
| author_sort |
L. A. Miroshnichenko |
| journal |
Разработка и регистрация лекарственных средств |
| journalStr |
Разработка и регистрация лекарственных средств |
| callnumber-first-code |
H |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
txt |
| container_start_page |
60 |
| author_browse |
L. A. Miroshnichenko T. Yu. Polyakova E. Yu. Avdeeva S. V. Krivoshchekov I. A. Khlusov M. V. Belousov |
| container_volume |
11 |
| class |
HD9665-9675 |
| format_se |
Elektronische Aufsätze |
| author-letter |
L. A. Miroshnichenko |
| doi_str_mv |
10.33380/2305-2066-2022-11-4-60-71 |
| author2-role |
verfasserin |
| title_sort |
chelidonic acid and its derivates: general spectrum of biological activity and osteogenic properties (review) |
| callnumber |
HD9665-9675 |
| title_auth |
Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) |
| abstract |
Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. |
| abstractGer |
Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. |
| abstract_unstemmed |
Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA |
| container_issue |
4 |
| title_short |
Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review) |
| url |
https://doi.org/10.33380/2305-2066-2022-11-4-60-71 https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e https://www.pharmjournal.ru/jour/article/view/1359 https://doaj.org/toc/2305-2066 https://doaj.org/toc/2658-5049 |
| remote_bool |
true |
| author2 |
T. Yu. Polyakova E. Yu. Avdeeva S. V. Krivoshchekov I. A. Khlusov M. V. Belousov |
| author2Str |
T. Yu. Polyakova E. Yu. Avdeeva S. V. Krivoshchekov I. A. Khlusov M. V. Belousov |
| ppnlink |
1760622966 |
| callnumber-subject |
HD - Industries, Land Use, Labor |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.33380/2305-2066-2022-11-4-60-71 |
| callnumber-a |
HD9665-9675 |
| up_date |
2024-07-03T18:54:28.516Z |
| _version_ |
1803585185138081792 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ088666379</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503024031.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230410s2022 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.33380/2305-2066-2022-11-4-60-71</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ088666379</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ7e2d42cd73ce42b0a861dbe8ef7e642e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665-9675</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">L. A. Miroshnichenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chelidonic Acid and its Derivates: General Spectrum of Biological Activity and Osteogenic Properties (Review)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction. The development and implementation of new effective and safe drugs with osteogenic activity is an urgent problem of modern medical and pharmaceutical sciences. This is due to the wide prevalence and complexity of the treatment of diseases of the musculoskeletal system, which entails significant economic costs for the treatment and recovery of this group of patients. Recently, standard therapy regimens are increasingly being supplemented with drugs derived from medicinal plants, which is associated with their rather pronounced therapeutic effect and the absence or mild side effects compared to more expensive modern medical analogues. In this regard, the development of new directions in the strategy for the development of pharmacological agents from plant sources becomes relevant. The study of plant secondary metabolites is one such area that has already yielded good results in relation to the development of such drugs, and holds great promise. The review provides information on the biological properties of chelidonic acid and its possible derivatives in order to demonstrate the prospects for the use of these objects for the development of drugs, including those with osteogenic activity.Text. Chelidonic acid is a substance present in many medicinal plants and has a wide range of pharmacological effects – analgesic, antimicrobial, anti-inflammatory, oncostatic and sedative. At the moment, methods have been developed for obtaining chelidonic acid and its derivatives from natural sources. In addition, chelidonic acid belongs to the so-called “small” molecules with osteogenic properties, which makes it promising in the creation of drugs for the treatment of diseases of the musculoskeletal system caused by impaired formation and regeneration of bone tissue. Native chelidonic acid has a low osteogenic activity, but given its ability to form complex compounds, it can act as a delivery system for osteoprotective micro- and macroelements. So, calcium chelidonate in experiments in vitro and in vivo shows a pronounced osteogenic activity: it stimulates the viability, adhesion and osteogenic differentiation of mesenchymal stem cells, enhances the mineralization of the extracellular matrix.Conclusion. Taking into account the wide range of biological activity of chelidonic acid, its use in the complex therapy of allergies, depression, diabetes mellitus, inflammatory diseases, malignant neoplasms and other pathological conditions seems relevant. Calcium chelidonate is a promising drug candidate that can be used to accelerate regeneration processes and in bone tissue engineering.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">хелидоновая кислота</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">хелидонат кальция</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">производные γ-пирона</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеогенная активность</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеопротекторы</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">T. Yu. Polyakova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. Yu. Avdeeva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Krivoshchekov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. A. Khlusov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. V. Belousov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Разработка и регистрация лекарственных средств</subfield><subfield code="d">LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020</subfield><subfield code="g">11(2022), 4, Seite 60-71</subfield><subfield code="w">(DE-627)1760622966</subfield><subfield code="x">26585049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:60-71</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.33380/2305-2066-2022-11-4-60-71</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/7e2d42cd73ce42b0a861dbe8ef7e642e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.pharmjournal.ru/jour/article/view/1359</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2305-2066</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">4</subfield><subfield code="h">60-71</subfield></datafield></record></collection>
|
| score |
7.399987 |